`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`LUPIN LTD. AND LUPIN PHARMACEUTICALS, INC.,
`Petitioners
`
`v.
`
`HORIZON THERAPEUTICS, LLC,
`Patent Owner
`
`
`
`
`
`
`
`
`Case IPR2016-00829
`Patent 9,095,559
`
`
`
`
`
`
`
`
`
`PATENT OWNER HORIZON THERAPEUTICS, LLC’S
`NOTICE OF APPEAL
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Director of the United States Patent and Trademark Office
`c/o Office of the General Counsel
`United States Patent and Trademark Office
`Madison Building East, Room 10B20
`600 Dulany Street
`Alexandria, VA 22313
`
`
`
`
`
`
`
`
`IPR2016-00829
`Patent No. 9,095,559
`Patent Owner Horizon’s Notice of Appeal
`
`
`Notice is hereby given, pursuant to 35 U.S.C. §§ 141(c), 142, 319; 37 C.F.R.
`
`§ 90.2(a), 90.3(a); and Federal Circuit Rule 15(a), that Patent Owner Horizon
`
`Therapeutics, LLC (“Horizon”) appeals from the Final Written Decision of the
`
`Patent Trial and Appeal Board (“Board”) entered on September 26, 2017 (Paper No.
`
`42) in the above-captioned inter partes review of U.S. Patent No. 9,095,559 (“the
`
`’559 patent”) to the United States Court of Appeals for the Federal Circuit.
`
`Horizon’s appeal includes any underlying orders, decisions, rulings, and opinions as
`
`well as any issues raised during these proceedings. This notice is timely filed
`
`within 63 days of the Board’s Final Written Decision. 37 C.F.R. § 90.3(a)(1).
`
`In accordance with 37 C.F.R. § 90.2(a)(3)(ii), Horizon states that the issues
`
`on appeal include, but are not limited to:
`
`(1)
`
`the Board’s failure to observe procedure required by law, including,
`
`but not limited to, 5 U.S.C. § 554, 556, and 557, 35 U.S.C. § 316,
`
`including, for example, by basing its Final Written Decision on facts
`
`and/or law other than those advanced in the Petition or stated to be part
`
`of the grounds upon which trial was instituted in the Institution
`
`Decision;
`
`(2)
`
`the Board’s violation of Horizon’s Due Process rights under U.S.
`
`Constitution Amendment V by failing to provide requisite notice and
`
`2
`
`
`
`IPR2016-00829
`Patent No. 9,095,559
`Patent Owner Horizon’s Notice of Appeal
`
`
`
`a full and fair opportunity to respond, including, for example, by
`
`basing its Final Written Decision on facts and/or law other than those
`
`advanced in the Petition or stated to be part of the grounds upon which
`
`trial was instituted in the Institution Decision;
`
`(3)
`
`the Board exceeding its statutory authority, including, for example, by
`
`basing its Final Written Decision on facts and/or law other than those
`
`advanced in the Petition or stated to be part of the grounds upon which
`
`trial was instituted in the Institution Decision;
`
`(4)
`
`the Board’s impermissible shifting of the burden to Horizon to show
`
`patentability of the challenged ’559 patent claims in violation of 35
`
`U.S.C. § 316(e), 5 U.S.C. § 556(d), and 37 C.F.R. § 42.20(c);
`
`(5)
`
`the Board’s determination
`
`that Petitioner has proved by a
`
`preponderance of the evidence that claims 1-15 of the ’559 patent are
`
`unpatentable under 35 U.S.C. § 103, including, without limitation, the
`
`Board’s construction and application of the claim language, the
`
`Board’s interpretation of the references, and the Board’s interpretation
`
`of expert evidence;
`
`(6)
`
`the Board’s determination of obviousness of claims 1-15 of the ’559
`
`patent without support of substantial evidence;
`
`3
`
`
`
`IPR2016-00829
`Patent No. 9,095,559
`Patent Owner Horizon’s Notice of Appeal
`
`
`
`the Board’s Final Written Decision’s dependence upon
`
`(7)
`
`misinterpretation of the prior art;
`
`(8) whether inter partes review violates Horizon’s rights under U.S.
`
`Constitution Amendment VII by extinguishing private property rights
`
`through a non-Article III forum without a jury; and
`
`(9)
`
`any findings or determinations related to issues (1)-(8) as well as all
`
`other issues decided adversely to Horizon in any orders, decisions,
`
`rulings and/or opinions.
`
`Simultaneous with this submission, Horizon is filing a true and correct copy
`
`of this Notice of Appeal with the Director of the U.S. Patent and Trademark Office
`
`and electronically filing the same, along with the required docketing fees, with the
`
`Clerk of the U.S. Court of Appeals for the Federal Circuit as set forth in the
`
`accompanying Certificate of Filing.
`
`
`
`Date: November 22, 2017
`
`
`
`
`
`Respectfully submitted,
`
`By: /s/Robert F. Green
`Robert F. Green
`Registration No. 27,555
`Counsel for Patent Owner,
`Horizon Therapeutics, LLC
`
`4
`
`
`
`
`
`CERTIFICATE OF FILING
`
`The undersigned hereby certifies that, in addition to being electronically
`
`filed through USPTO Patent Trial and Appeal Board End-to-End System, a true
`
`and correct copy of the above-captioned “PATENT OWNER HORIZON
`
`THERAPEUTIC LLC’S NOTICE OF APPEAL” is being filed by hand with the
`
`Director of the U.S. Patent and Trademark Office on November 22, 2017, at the
`
`following address:
`
`Director of the United States Patent and Trademark Office
`c/o Office of the General Counsel
`United States Patent and Trademark Office
`Madison Building East, Room 10B20
`600 Dulany Street
`Alexandria, VA 22313
`
`
`The undersigned also hereby certifies that a true and correct copy of the
`
`above-captioned “PATENT OWNER HORIZON THERAPEUTIC LLC’S
`
`NOTICE OF APPEAL” and the filing fee is being filed via the electronic filing
`
`system, CM/ECF, with the Clerk’s Office of the U.S. Court of Appeals for the
`
`Federal Circuit on November 22, 2017.
`
`Dated: November 22, 2017
`
`
`
`
`Respectfully submitted,
`
`/s/Robert F. Green
`Robert F. Green
`Registration No. 27,555
`Counsel for Patent Owner,
`Horizon Therapeutics, LLC
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on November 22, 2017, a copy of the foregoing
`
`
`
`“PATENT OWNER HORIZON THERAPEUTIC LLC’S NOTICE OF APPEAL”
`
`was served via electronic mail, as agreed to by counsel, upon the following counsel
`
`for the Petitioners:
`
`Elizabeth J. Holland: eholland@goodwinlaw.com
`
`Cynthia Lambert Hardman: chardman@goodwinlaw.com
`
`Robert V. Cerwinski: rcerwinski@goodwinlaw.com
`
`/s/Robert F. Green
`Robert F. Green
`Registration No. 27,555
`Counsel for Patent Owner,
`Horizon Therapeutics, LLC
`
`
`
`
`
`
`